Preclinical aspects of anti-VEGF agents for the treatment of wet AMD: ranibizumab and bevacizumab

2011139 citationsReviewbronze Open Access

Authors

Good health and well-being

Published in: Eye

Volume 25, Issue 6, pp. 661-672

Field-Weighted Citation Impact: 13.73